These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 26148319)

  • 1. A Qualitative Study Exploring the Perceptions of Sedentary Behavior in Prostate Cancer Survivors Receiving Androgen-Deprivation Therapy.
    Trinh L; Arbour-Nicitopoulos KP; Sabiston CM; Alibhai SM; Jones JM; Berry SR; Loblaw A; Faulkner GE
    Oncol Nurs Forum; 2015 Jul; 42(4):398-406. PubMed ID: 26148319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perceptions of physically active men with prostate cancer on the role of physical activity in maintaining their quality of life: possible influence of androgen deprivation therapy.
    Keogh JW; Patel A; MacLeod RD; Masters J
    Psychooncology; 2013 Dec; 22(12):2869-75. PubMed ID: 23904113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RiseTx: testing the feasibility of a web application for reducing sedentary behavior among prostate cancer survivors receiving androgen deprivation therapy.
    Trinh L; Arbour-Nicitopoulos KP; Sabiston CM; Berry SR; Loblaw A; Alibhai SMH; Jones JM; Faulkner GE
    Int J Behav Nutr Phys Act; 2018 Jun; 15(1):49. PubMed ID: 29880049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perceived barriers and facilitators to physical activity in men with prostate cancer: possible influence of androgen deprivation therapy.
    Keogh JW; Patel A; MacLeod RD; Masters J
    Eur J Cancer Care (Engl); 2014 Mar; 23(2):263-73. PubMed ID: 24134506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exercise preferences among men with prostate cancer receiving androgen-deprivation therapy.
    Harrington JM; Schwenke DC; Epstein DR
    Oncol Nurs Forum; 2013 Sep; 40(5):E358-67. PubMed ID: 23989028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term quality of life in disadvantaged men with prostate cancer on androgen-deprivation therapy.
    Sevilla C; Maliski SL; Kwan L; Connor SE; Litwin MS
    Prostate Cancer Prostatic Dis; 2012 Sep; 15(3):237-43. PubMed ID: 22289781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of light physical activity, moderate-to-vigorous physical activity and sedentary behavior with quality of life in men on androgen deprivation therapy for prostate cancer: a quantile regression analysis.
    Trinh L; Alibhai SMH; Culos-Reed N; Sabiston CM; Jones JM; Rosenberg DE; Whitehorn A; Bastas D; Faulkner GE
    J Behav Med; 2022 Aug; 45(4):533-543. PubMed ID: 35061159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing eccentric resistance exercise in prostate cancer survivors on and off hormone therapy: a pilot study.
    Hansen PA; Dechet CB; Porucznik CA; LaStayo PC
    PM R; 2009 Nov; 1(11):1019-24. PubMed ID: 19942188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival outcomes in men receiving androgen-deprivation therapy as primary or salvage treatment for localized or advanced prostate cancer: 20-year single-centre experience.
    DiBlasio CJ; Malcolm JB; Hammett J; Wan JY; Aleman MA; Patterson AL; Wake RW; Derweesh IH
    BJU Int; 2009 Nov; 104(9):1208-14. PubMed ID: 19388987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of physical activity and quality of life in New Zealand prostate cancer survivors undergoing androgen-deprivation therapy.
    Keogh JW; Shepherd D; Krägeloh CU; Ryan C; Masters J; Shepherd G; MacLeod R
    N Z Med J; 2010 Nov; 123(1325):20-9. PubMed ID: 21317957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance Exercise Reduces Body Fat and Insulin During Androgen-Deprivation Therapy for Prostate Cancer.
    Winters-Stone KM; Dieckmann N; Maddalozzo GF; Bennett JA; Ryan CW; Beer TM
    Oncol Nurs Forum; 2015 Jul; 42(4):348-56. PubMed ID: 26148314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The lived experience of physically active older prostate cancer survivors on androgen deprivation therapy.
    Wright-St Clair VA; Malcolm W; Keogh JW
    Aging Male; 2014 Mar; 17(1):57-62. PubMed ID: 23862577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen-deprivation therapy and metabolic syndrome in men with prostate cancer.
    Harrington JM; Schwenke DC; Epstein DR; Bailey DE
    Oncol Nurs Forum; 2014 Jan; 41(1):21-9. PubMed ID: 24368236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exercise improves quality of life in androgen deprivation therapy-treated prostate cancer: systematic review of randomised controlled trials.
    Teleni L; Chan RJ; Chan A; Isenring EA; Vela I; Inder WJ; McCarthy AL
    Endocr Relat Cancer; 2016 Feb; 23(2):101-12. PubMed ID: 26584972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving Physical and Mental Health in Patients with Prostate Cancer Undergoing Androgen Deprivation Therapy: Strategies to Promote and Improve Physical Activity Quality and Quantity.
    Toohey K; McKune A; Nahon I; Kavanagh PS; Newton RU; Paterson C
    Semin Oncol Nurs; 2020 Aug; 36(4):151051. PubMed ID: 32682582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 'You know I've joined your club… I'm the hot flush boy': a qualitative exploration of hot flushes and night sweats in men undergoing androgen deprivation therapy for prostate cancer.
    Eziefula CU; Grunfeld EA; Hunter MS
    Psychooncology; 2013 Dec; 22(12):2823-30. PubMed ID: 23893467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen deprivation therapy: evidence-based management of side effects.
    Ahmadi H; Daneshmand S
    BJU Int; 2013 Apr; 111(4):543-8. PubMed ID: 23351025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).
    Kawakami J; Cowan JE; Elkin EP; Latini DM; DuChane J; Carroll PR;
    Cancer; 2006 Apr; 106(8):1708-14. PubMed ID: 16544313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Information needs of men on androgen deprivation therapy.
    Soeyonggo T; Warde P; Fleshner N; Timilshina N; Alibhai SM
    BJU Int; 2012 May; 109(10):1503-9. PubMed ID: 21883845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoting general health during androgen deprivation therapy (ADT): a rapid 10-step review for your patients.
    Moyad MA
    Urol Oncol; 2005; 23(1):56-64. PubMed ID: 15885584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.